CHCT:NYE-Community Healthcare Trust Incorporated (USD)

COMMON STOCK | REIT-Healthcare Facilities | NYE

Last Closing Price

USD 48.06

Change

-0.63 (-1.29)%

Market Cap

USD 1.17B

Volume

0.10M

Average Target Price

USD 49.50 (+3.00%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. The Company had investments of approximately $667.3 million in 131 real estate properties as of September 30, 2020, located in 33 states, totaling approximately 2.8 million square feet.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-05 )

Largest Industry Peers for REIT-Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WELL Welltower Inc

-2.26 (-3.02%)

USD32.02B 43.78 38.81
VTR Ventas, Inc

-2.05 (-3.70%)

USD20.76B 47.32 16.76
MPW Medical Properties Trust, Inc

-0.48 (-2.23%)

USD12.58B 22.87 18.42
OHI Omega Healthcare Investors, In..

-1.44 (-3.87%)

USD8.80B 37.91 19.65
HTA Healthcare Trust of America, I..

-1.06 (-3.64%)

USD6.38B 121.42 21.10
HR Healthcare Realty Trust Incorp..

-1.14 (-3.55%)

USD4.54B 61.69 19.55
DOC Physicians Realty Trust

-0.39 (-2.10%)

USD3.91B 58.64 19.50
NHI National Health Investors, Inc

-2.35 (-3.24%)

USD3.36B 17.50 15.11
LTC LTC Properties, Inc

-1.22 (-2.95%)

USD1.63B 35.83 20.34
UHT Universal Health Realty Income..

-2.26 (-3.44%)

USD0.91B 44.59 22.82

ETFs Containing CHCT

Symbol Name Weight Mer Price(Change) Market Cap
HYUP Xtrackers High Beta High .. 0.00 % 0.20 %

+0.10 (+0.20%)

USD0.01B

Market Performance

  Market Performance vs.
Industry/Classification (REIT-Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.02% 64% D 34% F
Dividend Return 0.91% 7% F 46% F
Total Return 2.92% 43% F 33% F
Trailing 12 Months  
Capital Gain 22.60% 50% F 32% F
Dividend Return 4.32% 21% F 58% F
Total Return 26.93% 50% F 32% F
Trailing 5 Years  
Capital Gain 147.48% 100% A+ 86% B
Dividend Return 41.57% 100% A+ 92% A-
Total Return 189.04% 100% A+ 89% B+
Average Annual (5 Year Horizon)  
Capital Gain 21.03% 100% A+ 86% B
Dividend Return 5.64% 71% C- 88% B+
Total Return 26.67% 100% A+ 89% B+
Risk Return Profile  
Volatility (Standard Deviation) 18.89% 57% F 56% F
Risk Adjusted Return 141.23% 100% A+ 98% A+
Market Capitalization 1.17B 36% F 52% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT-Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 60.94 36% F 13% F
Price/Book Ratio 2.85 15% F 38% F
Price / Cash Flow Ratio 24.20 14% F 17% F
EV/EBITDA 26.91 23% F 21% F
Management Effectiveness  
Return on Equity 4.87% 57% F 46% F
Return on Invested Capital 4.66% 71% C- 53% F
Return on Assets 2.84% 57% F 61% D-
Debt to Equity Ratio 49.40% 71% C- 63% D
Technical Ratios  
Short Ratio 3.06 85% B 33% F
Short Percent 2.04% 85% B 69% D+
Beta 0.45 86% B 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.